Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. announced on 29 March 2023 the profit distribution proposal for 2022 as follows: Cash dividend (tax included) of CNY 8.00000000 per 10 shares.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Equities
301096
CNE1000056N5
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.47 CNY | -0.11% | -2.65% | -2.50% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.50% | 949M | |
+63.90% | 62.59B | |
-1.77% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.64% | 26.21B | |
-21.68% | 19.09B | |
+4.29% | 13.08B | |
+25.60% | 12.26B | |
+28.40% | 12.05B |
- Stock Market
- Equities
- 301096 Stock
- News Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
- Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Proposes Cash Dividend for the Year 2022